InvestorsHub Logo
Followers 17
Posts 899
Boards Moderated 0
Alias Born 09/28/2014

Re: None

Tuesday, 09/10/2019 1:39:12 PM

Tuesday, September 10, 2019 1:39:12 PM

Post# of 701433
If there is interest in INMB, Dr. Tesi is presenting INMB’s new product to at a conference this afternoon and webcast is available.

“LA JOLLA, Calif., Sept. 05, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, is pleased to announce that R.J. Tesi, M.D., the Company’s Co-founder and CEO, is scheduled to present at the H.C. Wainwright 21st Annual Healthcare Conference in New York City to introduce the NeuLiv™ program for treatment of NASH."

INMB's site page re conference with webcast link:

https://www.inmunebio.com/index.php/en/news-2/2019/291-muneiotoresentattheainwright21stnnuale20190905


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News